On Wednesday, I took part in a debate on widening the access to vital medicines. The Scottish Government has significantly improved access to new medicines in recent years, and furthermore, are currently in the process of implementing recommendations from a review which will mean faster access to new treatments.

Given ultra-orphan drugs are often very expensive, it is also vital that pharmaceutical companies play their part and bring a fair price, first time, to the process.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s